CANF Operating Income Growth
Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares · Operating Income Growth
CANF Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported4.45%period ending
CANF Quarterly Operating Income YoY % (-20.26% → 4.45%)
Year-over-year change
High-resolution chart · PNG
CANF operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 4.4508% | |
| 4.4508% | |
| -25.1735% | |
| -25.1735% | |
| -19.6385% | |
| -19.6385% | |
| -10.0327% | |
| -8.2037% | |
| -14.7422% | |
| 24.5206% | |
| 40.5125% | |
| 27.5165% | |
| 13.8164% | |
| -8.5669% | |
| 23.4608% | |
| 26.6952% | |
| 33.9291% | |
| -15.0622% | |
| -13.369% | |
| -41.5894% | |
| 18.2198% | |
| 49.2283% | |
| 22.8782% | |
| 11.1788% | |
| -32.3773% | |
| -149.9123% | |
| -84.0591% | |
| 56.8358% | |
| -47.1276% | |
| -7.7456% | |
| -4.3687% | |
| -453.679% | |
| -5.3585% | |
| 18.2578% | |
| 7.475% | |
| 48.6018% | |
| 12.0465% | |
| -17.9462% | |
| -8.6508% | |
| -69.0539% | |
| -44.2746% | |
| -35.6627% | |
| -43.7407% | |
| 2.368% | |
| 31.9829% | |
| 37.1908% | |
| 51.82% | |
| 11.2762% | |
| 0.8665% | |
| -12.2111% | |
| -64.5677% | |
| -29.293% | |
| -74.5385% | |
| -10.2592% | |
| -80.5463% | |
| -14.3481% | |
| 1.0071% | |
| -3.4499% | |
| -3.3785% | |
| -20.2582% |